• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Kogawa Takahiro  古川 孝広

ORCIDConnect your ORCID iD *help
Researcher Number 70444916
Affiliation (Current) 2025: 公益財団法人がん研究会, 有明病院 がん早期臨床開発部, 部長
Affiliation (based on the past Project Information) *help 2022 – 2023: 公益財団法人がん研究会, 有明病院 がん早期臨床開発部, 部長
2020 – 2021: 国立研究開発法人国立がん研究センター, 東病院, 非常勤医員
2019: 国立研究開発法人国立がん研究センター, 東病院, 非常勤医師
2017 – 2018: 国立研究開発法人国立がん研究センター, 東病院, 医員
Review Section/Research Field
Principal Investigator
Basic Section 55010:General surgery and pediatric surgery-related / General surgery
Keywords
Principal Investigator
TROP2 / HER3 / HER2 / 脳転移 / 乳がん / 免疫機能解析 / 腫瘍浸潤リンパ球 / 遺伝子発現 / トリプルネガティブ乳癌 / pCR … More / predictor / TILs / 免疫染色 / TNBC / 亜分類 / TIL / トリプルネガティブ乳がん Less
  • Research Projects

    (2 results)
  • Research Products

    (4 results)
  • Co-Researchers

    (6 People)
  •  乳がん脳転移症例におけるHER3等治療標的の探索Principal Investigator

    • Principal Investigator
      古川 孝広
    • Project Period (FY)
      2020 – 2024
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 55010:General surgery and pediatric surgery-related
    • Research Institution
      Japanese Foundation for Cancer Research
      National Cancer Center Japan
  •  New Classification of triple negative breast cancer (TNBC) based on immune status with clinical characteristicPrincipal Investigator

    • Principal Investigator
      Kogawa Takahiro
    • Project Period (FY)
      2017 – 2021
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      General surgery
    • Research Institution
      National Cancer Center Japan

All 2020 2019 2018

All Journal Article Presentation

  • [Journal Article] Use of Eribulin as an Earlier-Line Chemotherapy for Patients With HER2-negative Metastatic Breast Cancer2020

    • Author(s)
      Sumito Shingaki, Takahiro Kogawa, Mototsugu Shimokawa et al.
    • Journal Title

      Journal of Cancer

      Volume: 11(14) Issue: 14 Pages: 4099-4105

    • DOI

      10.7150/jca.37670

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-17K10570
  • [Journal Article] Overall survival and post-progression survival are potent endpoint in phase III trials of second/third-line chemotherapy for advanced or recurrent epithelial ovarian cancer2018

    • Author(s)
      Shimokawa Mototsugu、Kogawa Takahiro、Shimada Takako、Saito Toshiaki、Kumagai Hozumi、Ohki Masafumi、Kaku Tsunehisa
    • Journal Title

      Journal of Cancer

      Volume: 9 Issue: 5 Pages: 872-879

    • DOI

      10.7150/jca.17664

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-17K10570
  • [Presentation] Baseline neutrophil to lymphocyte ratio is predictor of longer OS of metastatic BC patients treated with eribulin2019

    • Author(s)
      楠原正太, 古川孝広, 下川元継 ら
    • Organizer
      第17回日本臨床腫瘍学会学術集会
    • Data Source
      KAKENHI-PROJECT-17K10570
  • [Presentation] Revisit the risk factors of recurrence in node involved HER2-positive breast cancer.2019

    • Author(s)
      長谷川依子, 古川孝広, 下川元継 ら
    • Organizer
      第17回日本臨床腫瘍学会学術集会
    • Data Source
      KAKENHI-PROJECT-17K10570
  • 1.  内藤 陽一 (90590373)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 0 results
  • 2.  土井 俊彦 (20522907)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 3.  設楽 紘平 (20730419)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 4.  藤井 誠志 (30314743)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 5.  原野 謙一 (80627258)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 6.  向原 徹 (80435718)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi